Type 1 diabetes

Lancet

Volumn 367, Issue 9513, 2006, Pages 847-858

  Daneman, Denis ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMYLIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EXENDIN 4; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; METFORMIN; NICOTINAMIDE;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DIABETES EDUCATION; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; DRUG MECHANISM; DRUG RELEASE; GENETIC SUSCEPTIBILITY; GLYCEMIC CONTROL; HLA SYSTEM; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 33644841145     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68341-4     Document Type: Conference Paper

References (147)

1. M Stumvoll, BJ Goldstein, TW van Haeften Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 2005 1333 1346
2. KMV Narayan, JP Boyle, TJ Thompson, SW Sorensen, DF Williamson Lifetime risk for diabetes in the United States JAMA 290 2003 1884 1890
3. American Diabetes Association Clinical practice recommendations Diabetes Care 28 suppl 1 2005 S1 S79
4. MJ Redondo, PR Fain, GS Eisenbarth Genetics of type 1A diabetes Recent Prog Horm Res 56 2001 69 89
5. AP Lambert, KM Gillespie, G Thomson Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom J Clin Endocrinol Metab 89 2004 4037 4043
6. D Devendra, E Liu, GS Eisenbarth Type 1 diabetes: recent developments BMJ 328 2004 750 754
7. N Abiru, E Kawasaki, K Eguch Current knowledge of Japanese type 1 diabetic syndrome Diabetes Metab Res Rev 18 2002 357 366
8. GS Eisenbarth Type I diabetes mellitus. A chronic autoimmune disease N Engl J Med 314 1986 1360 1368
9. S Anjos, C Polychronakos Mechanisms of genetic susceptibility to type 1 diabetes: beyond HLA Mol Genet Metab 81 2004 187 195
10. N Lammi, M Karvonen, J Tuomilehto Do microbes have a causal role in type 1 diabetes? Med Sci Monit 11 2005 RA63 RA69
11. DT Robles, GS Eisenbarth Type 1A diabetes induced by infection and immunization J Autoimmun 16 2001 355 362
12. T Helgason, MR Jonasson Evidence for a food additive as a cause of ketosis-prone diabetes Lancet 318 1981 716 720
13. HK Akerblom, O Vaarala, H Hyoty, J Ilonen, M Knip Environmental factors in the etiology of type 1 diabetes Am J Med Genet 115 2002 18 29
14. SM Virtanen, E Laara, E Hypponen Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group Diabetes 49 2000 912 917
15. O Vaarala, M Knip, J Paronen Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes Diabetes 48 1999 1389 1394
16. I Thorsdottir, A Ramel Dietary intake of 10- to 16-year-old children and adolescents in central and northern Europe and association with the incidence of type 1 diabetes Ann Nutr Metab 47 2003 267 275
17. JM Norris, K Barriga, G Klingensmith Timing of initial cereal exposure in infancy and risk of islet autoimmunity JAMA 290 2003 1713 1720
18. A Hviid, M Stellfeld, J Wohlfahrt, M Melbye Childhood vaccination and type 1 diabetes N Engl J Med 350 2004 1398 1404
19. LL Levitsky Childhood immunizations and chronic illness N Engl J Med 350 2004 1380 1382
20. JP Krischer, DD Cuthbertson, L Yu Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes J Clin Endocrinol Metab 88 2003 103 108
21. N Maclaren, M Lan, R Coutant Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives J Autoimmun 12 1999 279 287
22. JM Barker, KJ Barriga, L Yu Prediction of autoantibody positivity and progression to type 1 diabetes: diabetes autoimmunity study in the young (DAISY) J Clin Endocrinol Metab 89 2004 3896 3902
23. EB Sochett, D Daneman, C Clarson, RM Ehrlich Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children Diabetologia 30 1987 453 459
24. H Yki-Jarvinen, VA Koivisto Natural course of insulin resistance in type I diabetes N Engl J Med 315 1986 224 230
25. JM Barker, J Yu, L Yu Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups Diabetes Care 28 2005 850 855
26. O Kordonouri, R Hartmann, D Deiss, M Wilms, A Gruters-Kieslich Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty Arch Dis Child 90 2005 411 414
27. H Skovbjerg, L Tarnow, H Locht, HH Parving The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy Diabetologia 48 2005 1416 1417
28. JM Norris, K Barriga, EJ Hoffenberg Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease JAMA 293 2005 2343 2351
29. EAM Gale A missing link in the hygiene hypothesis Diabetologia 45 2002 588 594
30. TJ Wilkin The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes Diabetologia 44 2001 914 922
31. TM Ball, JA Castro-Rodriguez, KA Griffith, CJ Holberg, FD Martinez, AL Wright Siblings, day-care attendance, and the risk of asthma and wheezing during childhood N Engl J Med 343 2000 538 543
32. E von Mutius, FD Martinez, C Fritzsch, T Nicolai, P Reitmeir, HH Thiemann Skin test reactivity and number of siblings BMJ 308 1994 692 695
33. B Kaila, SP Taback The effect of day care exposure on the risk of developing type 1 diabetes: a meta-analysis of case-control studies Diabetes Care 24 2001 1353 1358
34. PR Betts, J Mulligan, P Ward, B Smith, TJ Wilkin Increasing body weight predicts the earlier onset of insulin dependent diabetes in childhood: Testing the 'Accelerator Hypothesis' (2) Diabet Med 22 2005 144 151
35. D Daneman Is the 'Accelerator Hypothesis' worthy of our attention? Diabet Med 22 2005 115 117
36. DB Dunger, MA Sperling, CL Acerini ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents Arch Dis Child 9 2004 188 194
37. C Levy-Marchal, CC Patterson, A Green EURODIAB ACE Study Group Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study Diabetologia 44 suppl 3 2001 B75 B80
38. GL Booth Short-term clinical consequences of diabetes in adults JC Gerstein RB Haynes Evidence-based diabetes care 2001 BC Decker Inc Hamilton, ON 68 106
39. J Curtis, J Hamilton, C Beck, M Frank, D Daneman Diagnosis and short-term consequences of diabetes in children and adolescents HC Gerstein RB Haynes Evidence-based diabetes care 2001 BC Decker Inc Hamilton, ON 107 123
40. P Onkamo, S Vaananen, M Karvonen, J Tuomilehto Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends Diabetologia 42 1999 1395 1403
41. KM Gillespie, SC Bain, AH Barnett The rising incidence of childhood type 1 diabetes and reduced contributions of high-risk HLA haplotypes Lancet 364 2004 1699 1700
42. th century Diabetes 51 2002 3353 3361
43. J Tuomilehto, M Karvonen, J Pitkaniemi Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. The Finnish Childhood Type I Diabetes Registry Group Diabetologia 42 1999 655 660
44. S Kautiainen, A Rimpela, A Vikat, SM Virtanen Secular trends in overweight and obesity among Finnish adolescents in 1977-1999 Int J Obes Relat Metab Disord 26 2002 544 552
45. M Karvonen, M Viil-Kajander, E Moltchanova, I Libman, R LaPorte, J Tuomilehto Incidence of childhood type 1 diabetes worldwide Diabetes Care 23 2000 1516 1526
46. XH Li, TL Li, Z Yang A nine-year prospective study on the incidence of childhood type 1 diabetes mellitus in China Biomed Environ Sci 13 2000 263 270
47. J Tuomilehto, M Karvonen, J Pitkaniemi Record-high incidence of type 1 diabetes mellitus in Finnish children Diabetologia 42 1999 655 660
48. M Karvonen, J Pitkanemi, J Tuomilehto Finnish Childhood Diabetes Registry Group The age of onset of type 1 diabetes in Finnish children has become younger Diabetes Care 22 1999 1066 1070
49. A Casu, C Pascutto, L Bernardinelli, M Songini Type 1 diabetes among Sardinian children is increasing: the Sardinian diabetes register for children aged 0-14 years (1989-1999) Diabetes Care 27 2004 1623 1629
50. EURODIAB ACE Study Group Variation and trends in incidence of childhood diabetes in Europe Lancet 355 2000 873 876
51. LA Newhook, J Curtis, D Hagerty High incidence of childhood type 1 diabetes in the Avalon Peninsula, Newfoundland, Canada Diabetes Care 27 2004 885 888
52. G Dahlquist, L Mustonen Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Study Group Acta Paediatr 89 2000 1231 1237
53. I Weets, IH De Leeuw, MV Du Caju The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000 Diabetes Care 25 2002 840 846
54. MS Tremblay, JD Willms Secular trends in the body mass index of Canadian children CMAJ 163 2000 1429 1433
55. S Chinn, JM Hughes, RJ Rona Trends in growth and obesity in ethnic groups in Britain Arch Dis Child 19 1998 162 166
56. NT Raymond, JR Jones, PG Swift Comparative incidence of type 1 diabetes in children aged under 15 years from South Asian and white or other ethnic backgrounds in Leicestershire, UK, 1989 to 1998 Diabetologia 44 suppl 3 2001 B32 B36
57. The Diabetes Control and Complication Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
58. Diabetes control and complications trial research group Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial J Pediatr 125 1994 177 188
59. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy N Engl J Med 342 2000 381 389
60. Diabetes control and complications trial/Epidemiology of diabetes interventions and complications research group Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of diabetes control and complications trial J Pediatr 139 2001 804 812
61. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus JAMA 287 2002 2563 2569
62. The Diabetes Control and Complication Trial Research Group Hypoglycemia in the diabetes control and complication trial research group Diabetes 46 1997 271 286
63. D Daneman Early diabetes-related complications in adolescents: risk factors and screening Horm Res 63 2005 75 85
64. CM Ryan, MO Geckle, TJ Orchard Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications Diabetologia 46 2003 940 948
65. C Ryan, A Vega, A Drash Cognitive deficits in adolescents who developed diabetes early in life Pediatrics 75 1985 921 927
66. AMA Brands, GJ Biessels, EHF de Haan, LJ Kappelle, RPC Kessels The effects of type 1 diabetes on cognitive performance: a meta-analysis Diabetes Care 28 2005 726 735
67. HB Mortensen, P Hougaard Comparison of metabolic control in a cross sectional study of 2873 children and adolescents with insulin-dependent diabetes from 18 countries Diabetes Care 20 1997 714 720
68. T Danne, HB Mortensen, P Hougaard Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group Diabetes Care 24 2001 1342 1347
69. ME Ford-Adams, NP Murphy, EJ Moore Insulin lispro, a potential role in preventing nocturnal hypoglycemia in young children with diabetes mellitus Diabet Med 20 2003 656 660
70. HP Chase, B Dixon, J Pearson Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine hagedorn insulin J Pediatr 143 2003 737 740
71. SK Garg, PA Gottlieb, ME Hisatomi Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine Diabetes Res Clin Pract 66 2004 49 56
72. RE Ratner, IB Hirsh, JL Neifing, TE Mecca, CA Wilson Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes Diabetes Care 23 2000 639 643
73. P Vague, JL Selam, S Skeie Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH Insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin Aspart Diabetes Care 26 2003 590 596
74. A Siebenhofer, J Plank, A Berghold, M Narath, R Gferer, TR Pieber Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus Cochrane Database Syst Rev 2 2004 CD003287
75. Canadian Diabetes Association 2003 Clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diab 27 suppl 2 2003 S21 S23
76. E Loveman, P Royle, N Waugh Specialist nurses in diabetes mellitus Cochrane Database Syst Rev 2 2003 CD003286
77. CM Renders, GD Valk, S Griffin, EH Wagner, JT Eijk, WJ Assendelft Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings Cochrane Database Syst Rev 1 2001 CD001481
78. S Griffin, AL Kinmonth Diabetes care: the effectiveness of systems for routine surveillance for people with diabetes Cochrane Database Syst Rev 2 2000 CD000541
79. JC Keers, H Groen, WJ Sluiter, J Bouma, TP Links Cost and benefits of a multidisciplinary intensive diabetes education programme J Eval Clin Pract 11 2005 293 303
80. DR Owens, B Zinman, GB Bolli Insulins today and beyond Lancet 358 2001 739 746
81. A Seibenhofer, J Plank, A Berghold Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy Diabetologia 47 2004 1895 1905
82. J Plank, A Siebenhofer, A Berhold Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus Arch Intern Med 165 2005 1337 1344
83. AJ Palmer, S Roze, WJ Valentine, I Smith, KU Wittrup-Jensen Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials Curr Med Res Opin 20 2004 1729 1746
84. J Colquitt, P Royle, N Waugh Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis Diabet Med 20 2003 863 866
85. JL Colquitt, C Green, MK Sidhu, D Hartwell, N Waugh Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes Health Technol Assess 43 2004 1 171
86. R Retnakaran, J Hochman, JH DeVries Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c Diabetes Care 27 2004 2590 2596
87. RP Radermecker, AJ Scheen Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness Diabetes Metab Res Rev 20 2004 178 188
88. American Diabetes Association Standards of medical care in diabetes Diabetes Care 27 suppl 1 2004 S15 S35
89. H Bui, K Perlman, D Daneman Glucose monitoring: future directions. Self-monitoring of blood glucose in children and teens with diabetes Pediatric Diabetes 6 2005 50 62
90. AJ Karter, LA Ackeron, JA Darbinian Self-monitoring of blood glucose levels and glycemic control : the Northern California Kaiser Permanente Diabetes registry Am J Med 111 2001 1 9
91. JM Evans, RW Newton, DA Ruta, TM MacDonald, RJ Stevenson, AD Morris Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database BMJ 319 1999 83 86
92. MJ Haller, MS Stalvey, JH Silverstein Predictors of control of diabetes: monitoring may be the key J Pediatr 144 2004 660 661
93. B Guerci, M Floriot, P Bohme Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs Diabetes Care 26 2003 582 589
94. DB Sacks ADA/EASD/IDF working group of the HbA1c assay Global harmonization of hemoglobin A1c Clin Chem 51 2005 681 683
95. M Steffes, P Cleary, D Goldstein Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study Clin Chem 51 2005 753 758
96. WV Tamborlane, C Kollman, MW Steffes Diabetes Research in Children Network (DirecNet) Study Group Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study Pediatr Diabetes 6 2005 13 16
97. American Diabetes Association Nutrition principles and recommendations in diabetes Diabetes Care 27 suppl 1 2004 S36 S46
98. MJ Franz, JP Bantle, CA Beebe Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications Diabetes Care 25 2002 148 198
99. J Brand-Miller, S Hayne, P Petocz, S Colagiuri Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials Diabetes Care 26 2003 2261 2267
100. AM Opperman, CS Venter, W Oosthuizen, RL Thompson, HH Vorster Meta-analysis of the health effects of using the glycaemic index in meal-planning Br J Nutr 92 2004 367 381
101. S Nordfeld, J Ludvigsson Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus J Pediatr Endocrinol Metab 18 2005 83 91
102. D Smith, SA Amiel Hypoglycaemia unawareness and the brain Diabetologia 45 2002 949 958
103. PE Cryer Diverse causes of hypoglycemia-associated autonomic failure in diabetes N Engl J Med 350 2004 2272 2279
104. MT Draelos, AM Jacobson, K Weinger Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia Am J Med 98 1995 135 144
105. CM Ryan, D Dulay, C Suprasongsin, DJ Becker Detection of symptoms by adolescents and young adults with type 1 diabetes during experimental induction of mild hypoglycemia: role of hormonal and psychological variables Diabetes Care 25 2002 852 858
106. EA Northam, PJ Anderson, R Jacobs, M Hughes, GL Warne, GA Werther Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset Diabetes Care 24 2001 1541 1546
107. American Diabetes Association Physical activity/exercise and diabetes Diabetes Care 27 suppl 1 2004 S58 S62
108. CE Mogensen, CK Chistensen Predicting diabetic nephropathy in insulin-dependent patients N Engl J Med 311 1984 89 93
109. GC Viberti, RD Hill, RJ Jarrett, A Argyropoulos, U Mahmud, H Keen Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 319 1982 1430 1432
110. BA Perkins, LH Ficociello, KH Silva, DM Finkelstein, JH Warram, AS Krolewski Regression of microalbuminuria in type 1 diabetes N Engl J Med 348 2003 2285 2293
111. P Finne, A Reunanen, S Stenman, PH Groop, C Gronhagen-Riska Incidence of end-stage renal disease in patients with type 1 diabetes JAMA 294 2005 1782 1787
112. DCCT/EDIC Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study JAMA 290 2003 2159 2167
113. P Fioretto, A Solini Antihypertensive treatment and multifactorial approach for renal protection in diabetes J Am Soc Nephrol 16 suppl 1 2005 S18 S21
114. HG Lovell Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria Cochrane Database Syst Rev 1 2001 CD002183
115. DS Fong, LP Aiello, FL Ferris 3rd, R Klein Diabetic retinopathy Diabetes Care 27 2004 2540 2553
116. R Klein, B Zinman, R Gardiner The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients Diabetes 54 2005 527 533
117. BA Perkins, V Bril Early vascular risk factor modification in type 1 diabetes N Engl J Med 352 2005 408 409
118. BA Perkins, V Bril Diagnosis and management of diabetic neuropathy Curr Diab Rep 2 2002 495 500
119. ML Lawson, HC Gerstein, E Tsui, B Zinman Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis Diabetes Care 22 suppl 2 1999 B35 B39
120. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Intensive diabetes therapy and carotid intima-medial thickness in type 1 diabetes N Engl J Med 348 2003 2294 2303
121. AM Jacobson, ST Hauser, J Willett, JI Wolfsdorf, L Herman Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus J Pediatr 131 1997 727 733
122. M Kovacs, D Goldston, DS Obrosky, S Iyengar Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus J Am Acad Child Adolesc Psychiatry 31 1992 1112 1119
123. AM Jacobson, JA Samson, K Weinger, CM Ryan Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? Int Rev Neurobiol 51 2002 455 479
124. JM Jones, ML Lawson, D Daneman, MP Olmsted, G Rodin Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study BMJ 320 2000 1563 1566
125. AC Rydall, GM Rodin, MP Olmsted, RG Devenyi, D Daneman Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus N Engl J Med 336 1997 1849 1854
126. SE Hampson, TC Skinner, J Hart Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review Health Technol Assess 5 2001 1 79
127. Diabetes Prevention Trial-Type 1 Diabetes Study group Effects of insulin in relatives of patients with type 1 diabetes mellitus N Engl J Med 346 2002 1685 1691
128. EA Gale, PJ Bingley, CL Emmett, T Collier European Nicotinamide Diabetes Intervention Trial (ENDIT) Group European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes Lancet 363 2004 925 931
129. EA Ryan, BW Paty, PA Senior, AM Shapiro Risks and side effects of islet transplantation Curr Diab Rep 4 2004 304 309
130. EA Ryan, BW Paty, PA Senior Five-year follow-up after clinical islet transplantation Diabetes 54 2005 2060 2069
131. M Hansson, A Tonning, U Frandsen Artifactual insulin release from differentiated embryonic stem cells Diabetes 53 2004 2603 2609
132. Y Dor, J Brown, OI Martinez, DA Melton Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation Nature 429 2004 41 46
133. TJ Orchard, JC Olson, JR Erbey Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes Care 26 2003 1374 1379
134. J Hamilton, E Cummings, V Zdravkovic, D Finegood, D Daneman Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial Diabetes Care 26 2003 138 143
135. L Meyer, P Bohme, I Delbachian The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients Diabetes Care 26 2003 1655
136. RA Heptulla, LM Rodriguez, L Bomgaars, MW Haymond The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes Diabetes 54 2005 1100 1107
137. CJ Bailey Drugs on the horizon for diabesity Curr Diab Rep 5 2005 353 359
138. MA Nauck, JJ Meier Glucagon-like peptide 1 and its derivatives in the treatment of diabetes Regul Pept 128 2005 135 148
139. K Fukami, ME Cooper, JM Forbes Agents in development for the treatment of diabetic nephropathy Expert Opin Investig Drugs 14 2005 279 294
140. MJ McQueen, E Lonn, HC Gerstein, J Bosch, S Yusuf The HOPE Study and its consequences Scand J Clin Lab Invest 240 2005 143 156
141. L Leiter The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract 68 suppl 2 2005 S3 S14
142. TM Davis, DG Bruce, WA Davis Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study Diabet Med 22 2005 551 553
143. C Feudtner A disease in motion: diabetes history and the new paradigm of transmuted disease Perspect Biol Med 39 1996 158 170
144. WH Herman, RC Eastman The effects of treatment on the direct costs of diabetes Diabetes Care 21 suppl 3 1998 C19 C24
145. DCCT Research Group Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial JAMA 276 1996 1409 1415
146. SP Laing, ME Jones, AJ Swerdlow, AC Burden, W Gatling Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes Diabetes Care 28 2005 1618 1623
147. EAM Gale Type 1 diabetes in the young: the harvest of sorrow foes on Diabetologia 48 2005 1435 1438